SCHEMBL27114134

SCHEMBL27114134

N=C(N)NCc1ccc(N2CCN(C(=O)CN)CC2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TP53 P04637 1/20 0.47
▸ POLB P06746 1/20 0.47
▸ LMNA P02545 3/20 0.45
▸ ITGB3 P05106 2/20 0.45
▸ ITGA2B P08514 2/20 0.45
▸ GFER P55789 3/20 0.44
▸ NPC1 O15118 1/20 0.44
▸ MAPT P10636 5/20 0.43
▸ MEN1 O00255 5/20 0.43
▸ KMT2A Q03164 5/20 0.43
▸ GAA P10253 4/20 0.43
▸ KDM4E B2RXH2 3/20 0.43
▸ ALOX15 P16050 3/20 0.43
▸ ALOX12 P18054 3/20 0.43
▸ ALDH1A1 P00352 3/20 0.43
▸ SMN1; SMN2 Q16637 3/20 0.43
▸ HSP90AA1 P07900 1/20 0.43
▸ HSP90AB1 P08238 1/20 0.43
▸ TSHR P16473 1/20 0.43
▸ MAPK1 P28482 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27114960 0.83 SMN1; SMN2 (0.44) TP53POLBLMNAITGB3ITGA2B
SCHEMBL27116715 0.83 SMN1; SMN2 (0.45) TP53POLBLMNAITGB3ITGA2B
SCHEMBL24891910 0.77 MAPT (0.53) TP53LMNANPC1MAPTMEN1
SCHEMBL27116714 0.76 F2 (0.41) TP53LMNAITGB3ITGA2BGFER
SCHEMBL27114132 0.76 F2 (0.41) LMNAITGB3ITGA2BGFERNPC1
SCHEMBL15650594 0.75 GFER (0.65) TP53POLBLMNAGFERNPC1
SCHEMBL27114055 0.74 MEN1 (0.50) POLBLMNAITGB3ITGA2BMAPT
SCHEMBL22542013 0.74 HTT (0.59) TP53POLBLMNAGFERMAPT
SCHEMBL14489710 0.74 POLB (0.69) POLBLMNAGFERMAPTMEN1
SCHEMBL8245954 0.74 MAPT (0.70) LMNAGFERNPC1MAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240066135-A1 DRUG CONJUGATES AND USES THEREOF SUPERTRANS MEDICAL LTD (IL) 2024-02-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240066135-A1 DRUG CONJUGATES AND USES THEREOF SLC7A1, ABCB11, SLC1A5 TP53 3499/4885POLB 4688/4885LMNA 4394/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback